Instil Bio, Inc.
Instil Bio, Inc. (TIL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TIL · as of Jun 9, 2026
Key Statistics
Explore Instil Bio, Inc. Data
til stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 42.9%
The TIL analyst consensus is Hold, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $7.00, representing -13.37% downside from the current price of $8.08.
Competitors & Peers
til competitorsTIL
ATOS
IFRX
MGNX
ONCY
PLRXStock Performance
Full HistoryAbout Instil Bio, Inc.
Instil Bio, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on devising novel therapeutic options for individuals battling cancer. A cornerstone of their research i…
what is instil bio, inc. · til stock overview · instil bio, inc. company profile · who is instil bio, inc. ceo · til NASDAQ · instil bio, inc. headquarters · instil bio, inc. business segments
About Stock Overview & Key Data
Instil Bio, Inc. (TIL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 19, 2021. As of the latest trading session, TIL stock price is $8.08, with a market capitalization of $54.8M. The stock has returned -76.96% over the past 12 months and -26.55% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Instil Bio, Inc. stock is Hold, with an average 12-month price target of $7.00. In fiscal year 2025, Instil Bio, Inc. reported revenue of — and net income of -$71.4M. For detailed data — including Instil Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Instil Bio, Inc. (TIL) stock price is $8.08. The stock is traded on NASDAQ under the ticker symbol TIL. The 52-week range is $5.67 – $42.79.